In this free webinar, learn about using a clinical trial simulation platform to generate auditable and reproducible digital evidence. Attendees will learn about jinkō, Novadiscovery's in silico clinical trial simulation platform. The featured speakers will discuss how jinkō is rethinking scientific literature review and can help refine criteria for patient eligibility in the next trial. Attendees will learn how jinkō is used to design, run and analyze the results of in silico trials. The speakers will discuss how jinkō is helping generate auditable and reproducible digital evidence for submission dossiers.
TORONTO, Jan. 11, 2023 /PRNewswire-PRWeb/ -- These past few years have marked the acceleration of the adoption of in silico techniques for more efficient and innovative clinical research. When embarking on a new R&D program, scientists face a strategic imperative to assemble the best and most relevant available data and insights.
Jinkō, Novadiscovery's in silico clinical trial simulation platform, has been designed to build and maintain a high-quality knowledge repository, allowing teams to seamlessly cooperate, both internally and with external thought leaders.
During the first part of this webinar, featured speaker Dr. Friehs, will explain her role and how she uses jinkō with her fellows to extract, classify and qualify pieces of knowledge in a systematic, transparent and traceable manner, and use these in research reports and literature reviews. After that, featured speaker Frédéric (CPO of Novadiscovery) will showcase how this knowledge is then leveraged directly within jinkō to help lower cost and ethical constraints as well as achieve greater trial efficiency through the design and simulation of in silico trials. This will be illustrated with two practical use cases using Nova's non-small cell lung cancer (NSCLC) disease model of epidermal growth factor receptor (EGFR) mutated lung adenocarcinoma (LUAD). First, by exploring a large range of doses and then by testing eligibility criteria refinement and its impact on treatment effectiveness.
Join this webinar to learn more about using a clinical trial simulation platform to generate auditable and reproducible digital evidence.
Join Frédéric Cogny, CPO, Novadiscovery; and Dr. Ingeborg Friehs, Boston Children's Hospital & Harvard Medical School, for the live webinar on Monday, January 30, 2023, at 11am EST (4pm GMT/UK).
For more information, or to register for this event, visit In Silico: From Knowledge Curation to Clinical Trial Simulation.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks
Share this article